7: 15 pm

Pharmaceutical giant Johnson & Johnson on Thursday applied for emergency situation authorization of its one-dose COVID-19 vaccine

The company’s shot is 66 percent effectiv e versus moderate to extreme cases of the deadly global pandemic, but it just needs a single dosage and uses strong protection versus hospitalization and death from the bug, Politico reported

The J&J vaccine would include an important 3rd alternative– together with Pfizer and Moderna shots– as the US has a hard time to distribute vaccines versus the coronavirus, which has actually killed more than 455,000 Americans, according to Johns Hopkins University, which is tracking the infection.

However, the J&J variation has proved less effective against a more aggressive stress of the virus found in South Africa, the report stated.

That stress, in addition to an alternative identified in the UK, has actually been found in the US.

However, the J&J vaccine provides a 3rd line of defense.

” Upon permission of our investigational COVID-19 vaccine for emergency situation usage, we are all set to begin shipping,” Paul Stoffels, the company’s chief scientific officer, said in a declaration. “We are working with fantastic seriousness to make our investigational vaccine available to the public as quickly as possible.”